Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus

NACompletedINTERVENTIONAL
Enrollment

970

Participants

Timeline

Start Date

June 30, 2000

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

estradiol

DRUG

ethinyl estradiol

DRUG

medroxyprogesterone

DRUG

norethindrone

Trial Locations (17)

10003

Hospital for Joint Diseases, New York

10019

Saint Luke's-Roosevelt Hospital Center, New York

10021

Hospital for Special Surgery, New York

11776

Rheumatology Associates of Long Island, Port Jefferson Station

15260

University of Pittsburgh, Pittsburgh

19104

University of Pennsylvania, Philadelphia

21205

Johns Hopkins University School of Medicine, Baltimore

27599

University of North Carolina, Chapel Hill

35294

University of Alabama Comprehensive Cancer Center, Birmingham

48109

University of Michigan Health Systems, Ann Arbor

53226

Medical College of Wisconsin, Milwaukee

60637

Pritzker School of Medicine, Chicago

77030

University of Texas- Houston Medical School, Houston

94143

University of California-San Francisco, San Francisco

90095-6951

University of California Los Angeles, Los Angeles

71130-3932

Louisiana State University School of Medicine, Shreveport

10467-2490

Montefiore Medical Center, The Bronx

All Listed Sponsors
collaborator

University of Alabama at Birmingham

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00006133 - Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter